Drug intelligence / Profile preview

ademetionine

Development stage
Unknown
Lead developer
Abbott
Modality
Small Molecules
Administration
Intravenous
01

Overview

Ganfunèng is a Chinese brand of ademetionine 1,4-butanedisulfonate, a stable salt of S-adenosylmethionine (SAMe). SAMe is a naturally occurring amino acid derivative that serves as a primary methyl donor in the body and is involved in the transsulfuration and polyamine synthesis pathways. Originally developed by Abbott Laboratories as Transmetil, it is approved for treating intrahepatic cholestasis in adults and during pregnancy. Beyond its hepatic indications, Ganfunèng is being investigated for its neuroprotective properties, specifically for the prevention of perioperative neurocognitive disorders (PND) in elderly patients. Its mechanism of action includes the inhibition of Phosphodiesterase 4B (PDE4B) and the modulation of methylation and antioxidant pathways. It is typically formulated as a freeze-dried powder for intravenous injection.

Brand names
GanfunèngGanfu'nengTransmetil
Other names
S-adenosylmethionineSAMeademetionine 1,4-butanedisulfonate
02

Targets

Beyond the preview

Go deeper on ademetionine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ademetionine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call